The Psychology Newsletter for Spring 2013 (.PDF, 690 KB) covers updates for the Science IV and V Buildings, profiles some of our faculty and alumni (both Graduate & Undergraduate), and highlights our Honors students and awards winners from 2012.
Associate Professor of Psychology
Ph.D., Wayne State University
Post-doctoral training: Wayne State University School of Medicine
Area: Behavioral Neuroscience
Office: Science IV, Room 363
Member of the Society for Neuroscience, the Movement Disorders Society, International Basal Ganglia Society and the Center for Development and Behavioral Neuroscience
Parkinson's Disease, Neuroplasticity, Drug Development.
Movement is an ancient and basic function that is integral to the survival of the individual and species. As such, disorders of movement have a profound impact upon all facets of life. One of the most common movement disorders is Parkinson's disease, a neurodegenerative disorder that compromises dopaminergic areas of the brain rendering the individual unable to initiate, coordinate and execute movement. By employing an animal model of Parkinson's disease and a combination of behavioral, neurochemical and neuroanatomical techniques our laboratory examines the role of various neurotransmitters and neurocircuits responsible for this debilitating disorder. As importantly, we explore pharmacological targets within the brain that may aid in the development of more efficacious treatment for the Parkinsonian patient. Current projects, funded by the National Institute of Neurological Disease and Stroke and the Michael J. Fox Foundation investigate neuroplasticity in the brain serotonin system that may provide a novel target for the reduction of parkinsonian symptoms and side effects that occur as a result of chronic drug therapy.
My goal as a mentor is to provide students with the necessary tools, both theoretical and technical, to become productive independent researchers. Throughout the course of graduate curricula and laboratory experience, students will have the opportunity to develop a unique scientific approach and master a number of behavioral, neurochemical and neuroanatomical techniques that will lead to the design, execution and communication of sound and innovative research questions.
Bhide, N., Paquette M.A., Lindenbach, D.L., Surrena, M.A., Goldenberg, A.A., Berger S.P. and Bishop, C. (2013). BMY-14802, a 5-HT1A receptor agonist attenuates L-DOPA and dopamine agonist-induced dyskinesia without affecting L-DOPA efficacy. Psychopharmacology (in press).
Eskow-Jaunarajs, K.L., George, J.A., Bishop, C. (2012). L-DOPA-induced dyregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease. Neuroscience 218, 243-256.
Lindenbach, D., Ostock, C.Y., Eskow Jaunarajs, K.L., Dupre, K.B., Barnum, C.J., Bhide, N. & Bishop, C. (2011). Behavioral and cellular modulation of L-DOPA-induced dyskinesia by β-adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat. Journal of Pharmacology and Experimental Therapeutics 337(3). 755-765.
Ostock, C.Y., Dupre, K.B., Eskow Jaunarajs, K.L., Walters, H., Button, T., Krolewski, D.M., Walker, P.D., and Bishop, C. (2011). Role of primary motor cortex in L-DOPA-induced dyskinesia and its modulation by 5-HT1A receptors. Neuropharmacology 61(4), 753-760.
Dupre, K.B., Ostock C.Y., Eskow Jaunarajs, K.L., Button, T., Savage, L.M., Wolf, W. and Bishop, C. (2011). Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic hemiparkinsonian rats. Experimental Neurology 229(2), 288-299.
Last Updated: 2/28/13